Researchers have found critical new insights into how cells defend against melanoma. The team describes how an enzyme called nicotinamide phosphoribosyltransferase, or NAMPT, initiates antitumor activity. The researchers suggest that new therapies strengthening this pathway in immune cells could be the foundation for more effective treatments against melanoma.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/05/210511123640.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/05/210511123640.htm
New research outlines a critical driver in an immune cell's defense against melanoma
![New research outlines a critical driver in an immune cell's defense against melanoma]()
Reviewed by cmakigo
on
May 12, 2021
Rating:
No comments:
Post a Comment